Related Experiment Video
Updated: May 16, 2026
08:02
In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction
Published on: January 22, 2020
Vitamin D analogs decrease in vitro secretion of RANTES and enhance the effect of budesonide
M Fraczek1, B Rostkowska-Nadolska, D Kusmierz
1Department of Otolaryngology, Wroclaw Medical University, Wroclaw, Poland. raucedo@wp.pl
Advances in Medical Sciences
|November 28, 2012
Summary
Vitamin D derivatives and budesonide significantly reduce RANTES in nasal polyp fibroblasts, offering a potential complementary therapy for chronic rhinosinusitis with nasal polyps (NP). Combinations show greater efficacy than monotherapy.
Area of Science:
- Immunology
- Otolaryngology
- Pharmacology
Background:
- Eosinophils are key inflammatory cells in rhinosinusitis with nasal polyps (NP).
- RANTES is a significant chemoattractant for eosinophils in NP pathogenesis.
Purpose of the Study:
- To investigate the effect of vitamin D (VD) derivatives on RANTES expression in nasal polyp fibroblasts.
- To evaluate the potential of VD derivatives as a complementary therapy for NP.
Main Methods:
- Nasal polyp fibroblasts from 16 patients were cultured and stimulated.
- Cells were treated with calcitriol, tacalcitol, or budesonide, alone and in combination.
- RANTES levels in culture supernatants were quantified using ELISA.
Main Results:
- Calcitriol and tacalcitol significantly reduced RANTES production in a dose-dependent manner.
- Combinations of budesonide with VD derivatives were more effective than monotherapy.
- Budesonide and tacalcitol in specific ratios markedly suppressed RANTES levels.
Conclusions:
- Active vitamin D compounds downregulate RANTES production, suggesting a role in chronic rhinosinusitis with NP therapy.
- Combination therapy with budesonide and VD derivatives demonstrates superior efficacy compared to monotherapy.
Related Concept Videos
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:23Role of Skin in Vitamin D Synthesis
The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin D3(cholecalciferol).
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin D3(cholecalciferol).
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms: